HLB Launches the 'Senyum-Senyum Raya' Campaign with a Raya Song by HLB Ambassador, Alif Satar
KUALA LUMPUR, Malaysia, March 24, 2025 /PRNewswire/ -- As the Hari Raya Aidilfitri celebration approaches, Hong Leong Bank and Hong Leong Islamic Bank ("HLB" or the "Bank") have launched a unique campaign themed 'Amalan' (Good practices),...
Evolve: The Latest GPU Benchmark Suite
Revolutionary tool redefines performance evaluation for the graphics industry BREDA, Netherlands, March 24, 2025 /PRNewswire/ -- Traverse Research, one of the leading companies in graphics research and development, today announced the global launch...
Registration is On! 2025 CWIEME Shanghai - Your Gateway to Innovation & Connections
SHANGHAI, March 24, 2025 /PRNewswire/ -- 2025 CWIEME Shanghai is proud to announce its 10th anniversary that will unfold at the Shanghai World Expo Exhibition & Convention Center on June 25-27. As a leading coil winding and electrical...
CStone Submits Application to the European Medicines Agency for New Indication of Sugemalimab in Stage III Non-Small Cell Lung Cancer
SUZHOU, China, March 24, 2025 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a biopharmaceutical company dedicated to developing innovative cancer therapies, today announced the submission of a Type II variation application to the...
Strider Named to Fast Company's 2025 List of Most Innovative Companies
Strategic intelligence firm ranked in the top ten for most innovative security company TOKYO, March 24, 2025 /PRNewswire/ -- Strider Technologies, Inc., the leading provider of strategic intelligence, has been named to Fast Company's prestigious...
Asia's First Single Stock Leveraged & Inverse Products to Debut on HKEX
HONG KONG, March 24, 2025 /PRNewswire/ -- CSOP Asset Management Limited (CSOP), the largest Leveraged & Inverse Products (L&I products) issuer in Hong Kong, is proud to announce the listing of Asia's first batch of 9 single stock L&I...
Innovent Dosed First Participant in Phase 3 Clinical Study of IBI354 (Novel HER2 ADC) for Platinum-resistant Ovarian Cancer
SAN FRANCISCO and SUZHOU, China, March 24, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of...
AIM Vaccine's mRNA Shingles Vaccine Approved by the US FDA to Begin Clinical Trials, AI-Enabled mRNA Major Vaccine Product Development Accelerates
HONG KONG, March 24, 2025 /PRNewswire/ -- AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on March 23, 2025, the company's independently developed mRNA shingles vaccine has recently received clinical trial...